← Back
Data updated: Mar 10, 2026
LUITPOLD
CardiovascularOncologyGastroenterology
LUITPOLD is a generic drug manufacturer focused on Cardiovascular, Oncology, Gastroenterology.
1972
Since
25
Drugs
-
Trials
163
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
HEPARIN SODIUM 2026-02-20
Labeling
HEPARIN SODIUM 2026-02-20
Labeling
KETOROLAC TROMETHAMINE 2026-01-22
Labeling
POTASSIUM CHLORIDE 2025-12-22
NITROGLYCERIN 2025-12-18
VERAPAMIL HYDROCHLORIDE 2025-11-24
POTASSIUM CHLORIDE 2025-11-20
ONDANSETRON HYDROCHLORIDE 2025-11-18
Labeling
ONDANSETRON HYDROCHLORIDE 2025-11-17
Labeling
ONDANSETRON HYDROCHLORIDE 2025-11-17
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
3 drugs
Oncology 17%
1 drugs
Gastroenterology 17%
1 drugs
Neurology 17%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Active (9)
Discontinued (16)
HEPARIN SODIUM POTASSIUM CHLORIDE LIDOCAINE HYDROCHLORIDE DEXAMETHASONE SODIUM PHOSPHATE THIAMINE HYDROCHLORIDE CYANOCOBALAMIN HEPARIN LOCK FLUSH CIMETIDINE HYDROCHLORIDE IBUTILIDE FUMARATE FENOLDOPAM MESYLATE AMINOPHYLLINE DROPERIDOL MANNITOL 25% BRETYLIUM TOSYLATE PYRIDOXINE HYDROCHLORIDE PIPERAZINE CITRATE
Company Info
- First Approval
- 1972-12-27
- Latest
- 2024-11-21
- Applications
- 30